Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Goodwill (2016 - 2025)

Haemonetics has reported Goodwill over the past 16 years, most recently at $606.8 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.26% year-over-year to $606.8 million; the TTM value through Dec 2025 reached $606.8 million, changed 0.26%, while the annual FY2025 figure was $604.3 million, 6.93% up from the prior year.
  • Goodwill for Q4 2025 was $606.8 million at Haemonetics, roughly flat from $606.1 million in the prior quarter.
  • Over five years, Goodwill peaked at $616.2 million in Q3 2024 and troughed at $465.0 million in Q4 2022.
  • A 5-year average of $525.5 million and a median of $468.4 million in 2021 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: soared 121.43% in 2021 and later fell 1.63% in 2025.
  • Year by year, Goodwill stood at $468.6 million in 2021, then dropped by 0.53% to $466.1 million in 2022, then rose by 19.07% to $555.0 million in 2023, then rose by 9.06% to $605.3 million in 2024, then increased by 0.26% to $606.8 million in 2025.
  • Business Quant data shows Goodwill for HAE at $606.8 million in Q4 2025, $606.1 million in Q3 2025, and $607.3 million in Q2 2025.